Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality

PLoS Biology

Volumn 16, Issue 6, 2018, Pages

  Rezende, Leandro Fórnias Machado de ^a   Rey López, Juan Pablo ^b   Sá, Thiago Hérick de ^a   Chartres, Nicholas ^c   Fabbri, Alice ^c   Powell, Lauren ^b   Stamatakis, Emmanuel ^b,c   Bero, Lisa ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; DRUG USE; FOOD INTAKE; HEALTH BEHAVIOR; HUMAN; META ANALYSIS; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PUBLISHING; RISK FACTOR; SEDENTARY LIFESTYLE; SMOKING; SYSTEMATIC REVIEW; HIGH RISK BEHAVIOR; MORTALITY; STATISTICS AND NUMERICAL DATA;

CARDIOVASCULAR DISEASES; HEALTH BEHAVIOR; HEALTH RISK BEHAVIORS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PRIMARY PREVENTION; PUBLICATION BIAS; RISK FACTORS; SYSTEMATIC REVIEWS AS TOPIC;

EID: 85049368973     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.2005761     Document Type: Article

References (91)

1. World Health Organization. The top 10 causes of death 2017 [cited 2017 November 27]. http://www.who.int/mediacentre/factsheets/fs310/en/.
2. Kelly P, Kahlmeier S, Gotschi T, Orsini N, Richards J, Roberts N, et al. Systematic review and meta-analysis of reduction in all-cause mortality from walking and cycling and shape of dose response relationship. Int J Behav Nutr Phys Act. 2014;11:132. doi: 10.1186/s12966-014-0132-x pmid: 25344355
3. Samitz G, Egger M, Zwahlen M, Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol. 2011;40(5):1382–400. doi: 10.1093/ije/dyr112 pmid: 22039197
4. Woodcock J, Franco OH, Orsini N, Roberts I, Non-vigorous physical activity and all-cause mortality: systematic review and meta-analysis of cohort studies. Int J Epidemiol. 2011;40(1):121–38. doi: 10.1093/ije/dyq104 pmid: 20630992
5. Hupin D, Roche F, Gremeaux V, Chatard JC, Oriol M, Gaspoz JM, et al. Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged >/ = 60 years: a systematic review and meta-analysis. Br J Sports Med. 2015;49(19):1262–7. doi: 10.1136/bjsports-2014-094306 pmid: 26238869
6. Biswas A, Oh PI, Faulkner GE, Bajaj RR, Silver MA, Mitchell MS, et al. Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med. 2015;162(2):123–32. doi: 10.7326/M14-1651 pmid: 25599350
7. Chau JY, Grunseit AC, Chey T, Stamatakis E, Brown WJ, Matthews CE, et al. Daily sitting time and all-cause mortality: a meta-analysis. PLoS ONE. 2013;8(11):e80000. doi: 10.1371/journal.pone.0080000 pmid: 24236168
8. Grontved A, Hu FB, Television viewing and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a meta-analysis. JAMA. 2011;305(23):2448–55. doi: 10.1001/jama.2011.812 pmid: 21673296
9. Wilmot EG, Edwardson CL, Achana FA, Davies MJ, Gorely T, Gray LJ, et al. Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia. 2012;55(11):2895–905. doi: 10.1007/s00125-012-2677-z pmid: 22890825
10. Ford ES, Caspersen CJ, Sedentary behaviour and cardiovascular disease: a review of prospective studies. Int J Epidemiol. 2012;41(5):1338–53. doi: 10.1093/ije/dys078 pmid: 22634869
11. Pandey A, Salahuddin U, Garg S, Ayers C, Kulinski J, Anand V, et al. Continuous Dose-Response Association Between Sedentary Time and Risk for Cardiovascular Disease: A Meta-analysis. JAMA cardiology. 2016;1(5):575–83. doi: 10.1001/jamacardio.2016.1567 pmid: 27434872
12. Sun JW, Zhao LG, Yang Y, Ma X, Wang YY, Xiang YB, Association Between Television Viewing Time and All-Cause Mortality: A Meta-Analysis of Cohort Studies. American journal of epidemiology. 2015;182(11):908–16. doi: 10.1093/aje/kwv164 pmid: 26568572
13. Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, de Gaetano G, Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis. Eur J Epidemiol. 2011;26(11):833–50. doi: 10.1007/s10654-011-9631-0 pmid: 22076059
14. Jayasekara H, English DR, Room R, MacInnis RJ, Alcohol consumption over time and risk of death: a systematic review and meta-analysis. Am J Epidemiol. 2014;179(9):1049–59. doi: 10.1093/aje/kwu028 pmid: 24670372
15. Roerecke M, Rehm J, Ischemic heart disease mortality and morbidity rates in former drinkers: a meta-analysis. Am J Epidemiol. 2011;173(3):245–58. doi: 10.1093/aje/kwq364 pmid: 21156750
16. Roerecke M, Rehm J, Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014;12:182. doi: 10.1186/s12916-014-0182-6 pmid: 25567363
17. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA, Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671. doi: 10.1136/bmj.d671 pmid: 21343207
18. Park JE, Choi TY, Ryu Y, Cho SI, The relationship between mild alcohol consumption and mortality in Koreans: a systematic review and meta-analysis. BMC Public Health. 2015;15:918. doi: 10.1186/s12889-015-2263-7 pmid: 26385795
19. Stockwell T, Zhao J, Panwar S, Roemer A, Naimi T, Chikritzhs T, Do "Moderate" Drinkers Have Reduced Mortality Risk? A Systematic Review and Meta-Analysis of Alcohol Consumption and All-Cause Mortality. J Stud alcohol and drugs. 2016;77(2):185–98.
20. Zheng YL, Lian F, Shi Q, Zhang C, Chen YW, Zhou YH, et al. Alcohol intake and associated risk of major cardiovascular outcomes in women compared with men: a systematic review and meta-analysis of prospective observational studies. BMC Public Health. 2015;15:773. doi: 10.1186/s12889-015-2081-y pmid: 26264040
21. Roerecke M, Rehm J, Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol. 2010;171(6):633–44. doi: 10.1093/aje/kwp451 pmid: 20142394
22. Roerecke M, Rehm J, Chronic heavy drinking and ischaemic heart disease: a systematic review and meta-analysis. Open Heart. 2014;1(1):e000135. doi: 10.1136/openhrt-2014-000135 pmid: 25332827
23. Gellert C, Schottker B, Brenner H, Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med. 2012;172(11):837–44. doi: 10.1001/archinternmed.2012.1397 pmid: 22688992
24. Lv X, Sun J, Bi Y, Xu M, Lu J, Zhao L, et al. Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: a systematic review and meta-analysis. Int J Cardiol. 2015;199:106–15. doi: 10.1016/j.ijcard.2015.07.011 pmid: 26188829
25. Sinha DN, Suliankatchi RA, Gupta PC, Thamarangsi T, Agarwal N, Parascandola M, et al. Global burden of all-cause and cause-specific mortality due to smokeless tobacco use: systematic review and meta-analysis. Tob Control. 2018;27(1):35–42. doi: 10.1136/tobaccocontrol-2016-053302 pmid: 27903956
26. Farvid MS, Ding M, Pan A, Sun Q, Chiuve SE, Steffen LM, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation. 2014;130(18):1568–78. doi: 10.1161/CIRCULATIONAHA.114.010236 pmid: 25161045
27. Graudal N, Jurgens G, Baslund B, Alderman MH, Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens. 2014;27(9):1129–37. doi: 10.1093/ajh/hpu028 pmid: 24651634
28. Hu D, Huang J, Wang Y, Zhang D, Qu Y, Fruits and vegetables consumption and risk of stroke: a meta-analysis of prospective cohort studies. Stroke. 2014;45(6):1613–9. doi: 10.1161/STROKEAHA.114.004836 pmid: 24811336
29. Li XY, Cai XL, Bian PD, Hu LR, High salt intake and stroke: meta-analysis of the epidemiologic evidence. CNS Neurosci Ther. 2012;18(8):691–701. doi: 10.1111/j.1755-5949.2012.00355.x pmid: 22742770
30. Musa-Veloso K, Binns MA, Kocenas A, Chung C, Rice H, Oppedal-Olsen H, et al. Impact of low v. moderate intakes of long-chain n-3 fatty acids on risk of coronary heart disease. Br J Nutr. 2011;106(8):1129–41. doi: 10.1017/S0007114511001644 pmid: 21736820
31. Pan A, Chen M, Chowdhury R, Wu JH, Sun Q, Campos H, et al. alpha-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012;96(6):1262–73. doi: 10.3945/ajcn.112.044040 pmid: 23076616
32. Poggio R, Gutierrez L, Matta MG, Elorriaga N, Irazola V, Rubinstein A, Daily sodium consumption and CVD mortality in the general population: systematic review and meta-analysis of prospective studies. Public Health Nutr. 2015;18(4):695–704. doi: 10.1017/S1368980014000949 pmid: 24848764
33. Schwingshackl L, Hoffmann G, Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies. Lipids Health Dis. 2014;13:154. doi: 10.1186/1476-511X-13-154 pmid: 25274026
34. Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ. 2014;349:g4490. Epub 2014/07/31. doi: 10.1136/bmj.g4490 pmid: 25073782
35. Chen GC, Yang J, Eggersdorfer M, Zhang W, Qin LQ, N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis. Scientific reports. 2016;6:28165. doi: 10.1038/srep28165 pmid: 27306836
36. Cheng P, Huang W, Bai S, Wu Y, Yu J, Zhu X, et al. BMI Affects the Relationship between Long Chain N-3 Polyunsaturated Fatty Acid Intake and Stroke Risk: a Meta-Analysis. Sci Rep. 2015;5:14161. doi: 10.1038/srep14161 pmid: 26369699
37. Cheng P, Wang J, Shao W, Liu M, Zhang H, Can dietary saturated fat be beneficial in prevention of stroke risk? A meta-analysis. Neurol Sci. 2016;37(7):1089–98. doi: 10.1007/s10072-016-2548-3 pmid: 26979840
38. de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ. 2015;351:h3978. doi: 10.1136/bmj.h3978 pmid: 26268692
39. Narain A, Kwok CS, Mamas MA, Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Clin Pract. 2016;70(10):791–805. doi: 10.1111/ijcp.12841 pmid: 27456347
40. Grisso JA, Making comparisons. Lancet. 1993;342(8864):157–60. pmid: 8101260
41. Whiting P, Savovic J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225–34. doi: 10.1016/j.jclinepi.2015.06.005 pmid: 26092286
42. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. doi: 10.1136/bmj.d4002 pmid: 21784880
43. Ioannidis JP, Trikalinos TA, An exploratory test for an excess of significant findings. Clinical Trials. 2007;4:245–53. doi: 10.1177/1740774507079441 pmid: 17715249
44. Dickersin K, The existence of publication bias and risk factors for its occurrence. JAMA. 1990;263(10):1385–9. pmid: 2406472
45. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG, Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291(20):2457–65. doi: 10.1001/jama.291.20.2457 pmid: 15161896
46. Kennedy D, The old file-drawer problem. Science (New York, NY). 2004;305(5683):451. doi: 10.1126/science.305.5683.451 pmid: 15273363
47. Newcombe RG, Towards a reduction in publication bias. BMJ. 1987;295(6599):656–9. pmid: 3117278
48. Colonna G, Ragone R, Referee bias. Nature. 1994;367(6459):108. doi: 10.1038/367108c0 pmid: 8114900
49. Turner EH, Knoepflmacher D, Shapley L, Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database. PLoS Med. 2012;9(3):e1001189. doi: 10.1371/journal.pmed.1001189 pmid: 22448149
50. Bukkapatnam RN, Gabler NB, Lewis WR, Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis. Prev Cardiol. 2010;13(2):84–90. doi: 10.1111/j.1751-7141.2009.00059.x pmid: 20377811
51. Kizer JR, Madias C, Wilner B, Vaughan CJ, Mushlin AI, Trushin P, et al. Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy. Am J Cardiol. 2010;105(9):1289–96. doi: 10.1016/j.amjcard.2009.12.051 pmid: 20403481
52. Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB, Meta-analysis of statin effects in women versus men. J Am Coll Cardiol. 2012;59(6):572–82. doi: 10.1016/j.jacc.2011.09.067 pmid: 22300691
53. Lv HL, Jin DM, Liu M, Liu YM, Wang JF, Geng DF, Long-term efficacy and safety of statin treatment beyond six years: a meta-analysis of randomized controlled trials with extended follow-up. Pharmacol Res. 2014;81:64–73. doi: 10.1016/j.phrs.2014.02.006 pmid: 24602799
54. Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med. 2010;170(12):1024–31. doi: 10.1001/archinternmed.2010.182 pmid: 20585067
55. Savarese G, Gotto AM, Jr.Paolillo S, D’Amore C, Losco T, Musella F, et al. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. J Am Coll Cardiol. 2013;62(22):2090–9. doi: 10.1016/j.jacc.2013.07.069 pmid: 23954343
56. Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011;(1):CD004816. doi: 10.1002/14651858.CD004816.pub4 pmid: 21249663
57. Tonelli M, Lloyd A, Clement F, Conly J, Husereau D, Hemmelgarn B, et al. Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ. 2011;183(16):E1189–202. doi: 10.1503/cmaj.101280 pmid: 21989464
58. Chou R, Dana T, Blazina I, Daeges M, Jeanne TL, Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016;316(19):2008–24. doi: 10.1001/jama.2015.15629 pmid: 27838722
59. Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattar N, et al. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. Eur Heart J. 2015;36(24):1536–46. doi: 10.1093/eurheartj/ehv072 pmid: 25802390
60. Teng M, Lin L, Zhao YJ, Khoo AL, Davis BR, Yong QW, et al. Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis. Drugs Aging. 2015;32(8):649–61. doi: 10.1007/s40266-015-0290-9 pmid: 26245770
61. Siontis GC, Ioannidis JP, Risk factors and interventions with statistically significant tiny effects. Int J Epidemiol. 2011;40(5):1292–307. doi: 10.1093/ije/dyr099 pmid: 21737403
62. Hemkens LG, Ewald H, Naudet F, Ladanie A, Shaw JG, Sajeev G, et al. Interpretation of epidemiological studies very often lacked adequate consideration of confounding. Journal of clinical epidemiology. 2017. doi: 10.1016/j.jclinepi.2017.09.013 pmid: 28943377
63. Egger M, Schneider M, Davey Smith G, Spurious precision? Meta-analysis of observational studies. BMJ. 1998;316(7125):140–4. pmid: 9462324
64. Stamatakis E, Weiler R, Ioannidis JP, Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review. Eur J Clin Invest. 2013;43(5):469–75. doi: 10.1111/eci.12074 pmid: 23521369
65. Moodie R, Stuckler D, Monteiro C, Sheron N, Neal B, Thamarangsi T, et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet. 2013;381(9867):670–9. doi: 10.1016/S0140-6736(12)62089-3 pmid: 23410611
66. Fanelli D, Costas R, Ioannidis JP, Meta-assessment of bias in science. Proc Natl Acad Sci U S A. 2017;114(14):3714–9. doi: 10.1073/pnas.1618569114 pmid: 28320937
67. Fanelli D, Redefine misconduct as distorted reporting. Nature. 2013;494(7436):149. doi: 10.1038/494149a pmid: 23407504
68. Ioannidis JP, The importance of potential studies that have not existed and registration of observational data sets. JAMA. 2012;308(6):575–6. doi: 10.1001/jama.2012.8144 pmid: 22871867
69. Bothwell LE, Greene JA, Podolsky SH, Jones DS, Assessing the Gold Standard—Lessons from the History of RCTs. N Engl J Med. 2016;374(22):2175–81. doi: 10.1056/NEJMms1604593 pmid: 27248626
70. Zarin DA, Tse T, Sheehan J, The Proposed Rule for U.S. Clinical Trial Registration and Results Submission. N Engl J Med. 2014;372(2):174–80. doi: 10.1056/NEJMsr1414226 pmid: 25539444
71. Taichman DB, Sahni P, Pinborg A, Peiperl L, Laine C, James A, et al. Data Sharing Statements for Clinical Trials—A Requirement of the International Committee of Medical Journal Editors. N Engl J Med. 2017;376(23):2277–9. doi: 10.1056/NEJMe1705439 pmid: 28581902
72. Munafò MR, Nosek BA, Bishop DVM, Button KS, Chambers CD, Percie du Sert N, et al. A manifesto for reproducible science. Nature Human Behaviour. 2017;1:0021. doi: 10.1038/s41562-016-0021
73. Ioannidis JA, The proposal to lower p value thresholds to.005. JAMA. 2018;319(14):1429–30. doi: 10.1001/jama.2018.1536 pmid: 29566133
74. Chartres N, Fabbri A, Bero LA, Association of industry sponsorship with outcomes of nutrition studies: A systematic review and meta-analysis. JAMA Internal Medicine. 2016;176(12):1769–77. doi: 10.1001/jamainternmed.2016.6721 pmid: 27802480
75. Serodio PM, McKee M, Stuckler D, Coca-Cola—a model of transparency in research partnerships? A network analysis of Coca-Cola’s research funding (2008–2016). Public Health Nutr. 2018:1–14. doi: 10.1017/S136898001700307X pmid: 29560842
76. Gomez-Garcia F, Ruano J, Gay-Mimbrera J, Aguilar-Luque M, Sanz-Cabanillas JL, Alcalde-Mellado P, et al. Most systematic reviews of high methodological quality on psoriasis interventions are classified as high risk of bias using ROBIS tool. J Clin Epidemiol. 2017;92:79–88. doi: 10.1016/j.jclinepi.2017.08.015 pmid: 28893571
77. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC medical research methodology. 2007;7:10. doi: 10.1186/1471-2288-7-10 pmid: 17302989
78. Xing D, Wang B, Zhang W, Yang Z, Hou Y, Chen Y, et al. Intra-articular hyaluronic acid injection in treating knee osteoarthritis: assessing risk of bias in systematic reviews with ROBIS tool. Int J Rheum Dis. 2017;20(11):1658–73. doi: 10.1111/1756-185X.13192 pmid: 29044993
79. Higgins JPT, G S, Cochrane Handbook for Systematic Reviews of InterventionsVersion 5.1.0 [updated March 2011]: The Cochrane Collaboration; 2011.
80. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L, Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676–80. doi: 10.1001/jama.295.6.676 pmid: 16467236
81. Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP, Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607. doi: 10.1136/bmj.g7607 pmid: 25555821
82. Owen N, Sparling PB, Healy GN, Dunstan DW, Matthews CE, Sedentary behavior: emerging evidence for a new health risk. Mayo Clin Proc. 2010;85(12):1138–41. doi: 10.4065/mcp.2010.0444 pmid: 21123641
83. Ioannidis JP, The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses. The Milbank quarterly. 2016;94(3):485–514. doi: 10.1111/1468-0009.12210 pmid: 27620683
84. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. doi: 10.1371/journal.pmed.0040296 pmid: 17941714
85. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12. pmid: 10789670
86. Moher D, Liberati A, Tetzlaff J, Altman DG, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535 pmid: 19622551
87. Ahmed I, Sutton AJ, Riley RD, Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey. BMJ. 2011;344:d7762. doi: 10.1136/bmj.d7762 pmid: 22214758
88. Ioannidis JPA, Clarifications on the application and interpretation of the test for excess significance and its extensions. J Math Psychol. 2013;57(5):184–7. http://dx.doi.org/10.1016/j.jmp.2013.03.002.
89. Egger M, Davey Smith G, Schneider M, Minder C, Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34. pmid: 9310563
90. Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J, Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024. doi: 10.1136/bmj.j5024 pmid: 29167102
91. Sterne JA, Gavaghan D, Egger M, Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53(11):1119–29. pmid: 11106885